Posts In: Biotech Investments

View Post

The Big Names, Smaller Newcomers, And Emerging Market Players In The Race For A COVID Cure

From prominent names such as Moderna to smaller newcomers such as Tyme Technologies to emerging market players such as Indian…Read More

View Post

Strategies For The Biotech Surge

As the race for a coronavirus vaccine heats up, biotech stocks are on fire. And traders are sharing their strategies…Read More

View Post

This Biotech Is Experiencing A Coronavirus Surge

While it could be a year or more before a vaccine for the new coronavirus is ready for market, significant…Read More

View Post

Panic Potential

Amid the panic over the new coronavirus that has led to unprecedented quarantines in China, and which has now made…Read More

View Post

2 Biotech Companies About To Publicly Reveal Details Of Their Promising Breast Cancer Drug Candidates

The San Antonio Breast Cancer Symposium, which is being held from December 10 to 14, has become one of the…Read More

View Post

A Treatment That Improves The Condition Of MS Patients Could Improve The Condition Of This Beaten-Up Biotech

Last year, this biotech firm had a $50 stock and $3 billion market cap. Today, it has a stock trading…Read More

View Post

ETFs For Biotech’s Positive Results

Amid the roller coaster of optimism and pessimism regarding trade talks with China in recent weeks, one thing that has…Read More

View Post

Biotech’s 2019 “Plot Twist”

After a rough end to 2018, with massive fund outflows in the fourth quarter, biotech’s condition has been improving in…Read More

View Post

Therapeutic Trifecta

With a promising cannabinoid pipeline, an alternative to the EpiPen, and a superior solution for opioid overdoses, this firm has…Read More

View Post

Biotech Is On The Mend

After finding itself among the most oversold sectors last year, biotech is having its best start to a year since…Read More